Precursor-to-product ratios reflect biochemical phenotype in congenital adrenal hyperplasia
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Precursor-to-product ratios in steroid hormone metabolism may accurately reflect enzymatic activity and production of metabolites relative to their disappearance. The purpose of this study was to explore the use of direct precursor-to-product steroid ratios to discriminate between infants with congenital adrenal hyperplasia (CAH) due to 21-α-hydroxylase deficiency and infants with no disorder, thus characterizing the biochemical phenotype in CAH. Deidentified dried blood spot samples from confirmed CAH cases identified by newborn screen (CAH-positive, N = 8) and from cases with no disorder (CAH-negative, N = 10) were obtained from the California State Newborn Screening Program. Samples (~6.25 mm circular spots) underwent methanol and water extraction (9:1 ratio). Deuterated steroids served as isotope internal standards. 17-α-hydroxyprogesterone (17-OHP), 11-deoxycortisol (S), androstenedione (A4) and cortisol (F) concentrations were determined by liquid chromatography–tandem mass spectrometry (LC–MS/MS), and the 17-OHP/S, 17-OHP/A4, and S/F ratios were calculated. The mean 17-OHP and A4 concentrations in samples from CAH cases were significantly increased when compared to cases with no disorder (p = 0.003 for both). 17-OHP/S and 17-OHP/A4 ratios were also significantly elevated in CAH cases (p = 0.007 and p < 0.001, respectively). In contrast, S and F concentrations and the S/F ratio were similar between the two groups. In CAH, the elevated 17-OHP/S ratio is a biomarker of diminished 21-α-hydroxylase activity, and the elevated 17-OHP/A4 ratio is a biomarker of adrenal androgen excess via increased 17,20-lyase activity. The similar S/F ratio indicates that the rate of production via 11-β-hydroxylase and disappearance of F is maintained in CAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 2×
“Infants with CAH due to 21-a-hydroxylase deficiency usually present with signs of androgen excess and diminished capacity for glucocorticoid production, with up to 75 % of cases exhibiting mineralocorticoid deficiency, which may lead to salt-wasting crisis (Speiser et al. 2010a).”
Joint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
Matern, D., Tortorelli, S., Oglesbee, D., Gavrilov, D., & Rinaldo, P. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0691-y · Cited by 217
Lacey, J. M., Minutti, C. Z., Magera, M. J., Tauscher, A. L., Casetta, B., McCann, M., Lymp, J., Hahn, S. H., Rinaldo, P., & Matern, D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027193 · Cited by 216 · cited 4×
“The ratio of (17-OHP ? A4)/F, developed by the Mayo Clinic, has been used as a ‘‘second-tier’’ test in neonatal screening to discriminate between true CAH cases and CAH neonates with transient 17-OHP elevation (Lacey et al. 2004; Matern et al. 2007).”
InfluentialJanzen, N., Peter, M., Sander, S., Steuerwald, U., Terhardt, M., Holtkamp, U., & Sander, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2890 · Cited by 211 · cited 9×
“These values also fall into the reported ranges for CAH-negative cases (1.10–79.4 nmol/L) and CAH-positive cases (2.24–427 nmol/L), respectively (Janzen et al. 2007).”
InfluentialFinkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192 · cited 1×
“However, 21-a-hydroxylase enzyme deficiency encompasses four major genotypes corresponding to: mild and severe non-classical, simple virilizing, and salt-wasting phenotypes (Finkielstain et al. 2011).”
Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia
Sarafoglou, K., Banks, K., Gaviglio, A., Hietala, A., McCann, M., & Thomas, W. (2012) · PEDIATRICS · doi:10.1542/peds.2012-1219 · Cited by 69
Use of steroid profiles in determining the cause of adrenal insufficiency
Holst, J. P., Soldin, S. J., Tractenberg, R. E., Guo, T., Kundra, P., Verbalis, J. G., & Jonklaas, J. (2007) · Steroids · doi:10.1016/j.steroids.2006.11.001 · Cited by 67 · cited 1×
“The advent of liquid chromatography–tandem mass spectrometry (LC–MS/MS) has enabled the application of steroid profiling to different clinical scenarios, such as differentiating the cause of adrenal insufficiency (Holst et al. 2007).”
Peter, M., Sippell, W. G., Lorenzen, F., Westphal, E., Willig, R. P., & Grosse-Wilde, H. (1990) · The Lancet · doi:10.1016/0140-6736(90)91185-d · Cited by 41 · cited 2×
“Peter et al. calculated pre- and post-corticotropin stimulated plasma steroid levels by RIA to identify CAH heterozygotes and found that heterozygotes had significantly higher post-corticotropin 17-OHP/S ratios than normal relatives (Peter et al. 1990).”
Cited by
Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow
Taylor, A. E., Keevil, B., & Huhtaniemi, I. T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0338 · Cited by 320
LC–MS/MS analysis of steroids in the clinical laboratory
Keevil, B. G. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.009 · Cited by 149
Lai, F., Srinivasan, S., & Wiley, V. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030063 · Cited by 32
Tieh, P. Y., Yee, J. K., Hicks, R. A., Mao, C. S., & Lee, W.-N. (2017) · Journal of Perinatology · doi:10.1038/jp.2016.223 · Cited by 19
Self-citation
Metadata
- Authors
- Hicks, R. A., Yee, J. K., Mao, C. S., Graham, S., Kharrazi, M., Lorey, F., & Lee, W. P.
- Venue
- Metabolomics
- Published
- 2013-06-23
- Volume
- 10
- Issue
- 1
- Pages
- 123-131
- ISSN
- 1573-3882 (ISSN-L)
- 1573-3890
- OpenAlex
- W1997207778
- Cited by
- 35
- References
- 10
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Precursor-to-product ratios reflect biochemical phenotype in congenital adrenal hyperplasia. https://app.cochat.ai/papers/10.1007/s11306-013-0558-1
- The paper
- Hicks, R. A., Yee, J. K., Mao, C. S., Graham, S., Kharrazi, M., Lorey, F., & Lee, W. P. (2014). Precursor-to-product ratios reflect biochemical phenotype in congenital adrenal hyperplasia. Metabolomics. https://doi.org/10.1007/s11306-013-0558-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.